Benefits and limitations of incretin-based therapies and sodium-glucose transporter 2 inhibitors on diabetic kidney disease

Journal

Journal of Internal Medicine of Taiwan

Journal Volume

27

Journal Issue

5

Pages

248-260

Date Issued

2016

Author(s)

DOI

10.6314/JIMT.2016.27(5).04

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011911815&doi=10.6314%2fJIMT.2016.27%285%29.04&partnerID=40&md5=81344791fb34100c9815539211be2832

https://scholars.lib.ntu.edu.tw/handle/123456789/531271

SDGs

[SDGs]SDG3

Publisher

Society of Internal Medicine of Taiwan

Type

journal article